Latest News - Stryker Corporation

Top Corporates Hub

Stryker Corporation

SYK | NYSE | United States
99
+13
Rank
$126.48B
Market Cap
$22.59B
+$ 2.1B
+10.25%
Revenue
$3.49B
-$ 0.18B
-4.9%
Earnings
53K
+1K
+1.92%
Employees
Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)

18.07.2026 03:15

On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...

Read More

Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus

18.07.2026 01:08

Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...

Read More

Stryker expands Mako robotics portfolio with full market release of Mako RPS

16.07.2026 13:05

Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.

Read More

Independent Testing Shows Which Business Security Products Actually Hold Up When It Matters

15.07.2026 08:00

When Iranian-linked hackers breached medical device maker Stryker in March 2026, they did not need a sophisticated zero-day exploit to cause chaos. Once inside, they triggered simultaneous factory resets on more than 200,000 corporate devices across 79 countries, grinding order processing, production and shipping to a halt for days. Two months later, Foxconn confirmed that the Nitrogen ransomware group had stolen an alleged 8 terabytes of data from its North American factories, including project

Read More

Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players

13.07.2026 11:28

Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Nerve Repair Biomaterials Market Report 2026" has been added to ResearchAn

Read More

Stryker: The Market Is Overreacting To One Disrupted Quarter

09.07.2026 09:18

Stryker (SYK) buy rating after a rare Q1 miss from a temporary cyber disruption. Full-year guidance holds; demand strong.

Read More

J&J's MedTech Segment Eyes Another Strong Quarter in Q2

06.07.2026 14:58

JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.

Read More

Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income

06.07.2026 10:50

When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.

Read More

Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income

06.07.2026 10:50

When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.

Read More

Stryker: The Reshaped Product Portfolio Will Drive Growth

02.07.2026 05:25

Stryker looks undervalued after a cyber incident, with 32 years of dividend hikes, strong cash flow and M&A growth. Learn more on SYK stock here.

Read More

Stryker to announce second quarter 2026 financial results

01.07.2026 12:00

Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter

Read More

Stryker (SYK) Stock Weighs DCF Upside Against High P/E After Recent Price Rebound

30.06.2026 12:07

If you are wondering whether Stryker stock is offering fair value or a potential opportunity right now, the key is understanding what the current price is actually reflecting. The stock last closed at US$330.52, with returns of 8.5% over the past week and 8.3% over the past month, while the return year to date is down 5.1% and the return over the past year is down 15.6%. Recent headlines around Stryker have kept the stock on many investors' watchlists, as the company continues to sit at the...

Read More

Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base

30.06.2026 10:07

On 27 June 2026, Stryker Corporation was removed from multiple Russell growth indexes, including the Russell 1000 Growth, Russell 3000 Growth, Russell Top 200 Growth, and Russell 3000E Growth benchmarks. This broad index removal matters because it can trigger compulsory selling by index-tracking funds, reshaping who owns Stryker shares and how they trade. Next, we’ll examine how Stryker’s removal from several Russell growth benchmarks could influence its existing investment narrative and...

Read More

Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss

26.06.2026 11:11

Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy right now. On June 5, Leerink reduced its price target for Stryker Corporation (NYSE:SYK) to $407 from $410 while keeping an Outperform rating on the company’s stock. The firm changed its SYK model in response to new 10-Q filings following the company’s first-quarter 2026 […]

Read More

What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks

25.06.2026 06:02

Stryker Corp. (NYSE:SYK) is one of the 10 best robotics and automation stocks to invest in. On May 26, Stryker Corp. (NYSE:SYK) introduced its Pangea Plating System to the European market. This hardware platform is built to treat many different types of bone fracture patterns. Orthopedic trauma surgeon at St. George’s University Hospital in London, […]

Read More

BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show?

22.06.2026 13:10

With a short percentage of shares outstanding of 1.63%, Stryker Corporation (NYSE:SYK) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, BofA lowered its price target on Stryker Corporation (NYSE:SYK) to $380 from $450 while maintaining a Buy rating on the shares. The firm cited a softer healthcare utilization environment highlighted by its services team and […]

Read More

3 of Wall Street’s Favorite Stocks to Consider Right Now

22.06.2026 12:51

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Read More

Stryker Corp (NYSE:SYK): A Top-Tier Dividend Growth Stock Built on Profitability and Financial Health

13.06.2026 10:10

Stryker offers a modest 1.17% yield with exceptional dividend safety and growth. Strong profitability and reasonable valuation make NYSE:SYK a quality dividend growth stock for long-term investors.

Read More